4 studies were found.

1.		Terminated	Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination Condition: HIV Infections
2.		Completed	An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /ml and Greater. Condition: HIV Infections
3.		Completed	An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 cells/ml Condition: HIV Infections
4.		Completed	A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega Condition: HIV Infections